KIAA0391 activation is intricately linked with the coordination of multiple signaling pathways that are fundamental to cellular function and homeostasis. The protein's activity can be indirectly enhanced by compounds that modulate the levels of intracellular messengers such as cAMP, a critical second messenger in various signaling cascades. Agents that activate adenylyl cyclase can lead to increased cAMP levels, thereby triggering a cascade that involves cAMP-dependent protein kinase A (PKA), ultimately influencing KIAA0391's activity. Similarly, the use of cAMP analogs and inhibitors of phosphodiesterases, which prevent cAMP breakdown, can also prolong and enhance the signaling events that lead to the protein's activation. In addition, modulation of the protein kinase C (PKC) pathway, known to intersect with numerous cellular functions, can have downstream effects that result in the heightened activity of KIAA0391, as PKC activation can lead to altered phosphorylation states of proteins within the same network.
Furthermore, the protein's function can be indirectly influenced by alterations in energy-sensing pathways, such as those regulated by AMP-activated protein kinase (AMPK), which can impact KIAA0391's role in cellular metabolism. The inhibition of protein tyrosine phosphatases, serine/threonine phosphatases, or specific kinases within the MAPK pathway, can all lead to a shift in the dynamic phosphorylation equilibrium, thus potentially increasing KIAA0391 activity. Compounds that inhibit glycogen synthase kinase 3 (GSK-3) may also contribute to the activation of KIAA0391 through their effects on the Wnt signaling pathway, which is known to have broad implications in cell signaling and regulation. Additionally, the availability of coenzymes such as NAD+, which are central to redox reactions and energy metabolism, could influence signaling pathways that indirectly enhance the functional activity of KIAA0391.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist, raises cAMP levels, potentially augmenting KIAA0391's function through the cAMP signaling pathway. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor, elevates intracellular cAMP, possibly supporting KIAA0391's activity through PKA-mediated phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Protein kinase C activator, may enhance KIAA0391's activity through PKC-related signaling pathways that intersect with KIAA0391's functional role. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AMPK activator, could indirectly promote KIAA0391 function by modulating energy-sensing pathways that KIAA0391 may regulate or be regulated by. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Inhibitor of protein tyrosine phosphatases, could indirectly increase KIAA0391 activity by enhancing tyrosine phosphorylation signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Serine/threonine phosphatase inhibitor, may indirectly elevate KIAA0391 activity by increasing phosphorylation within relevant signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog, directly augments cAMP-dependent pathways and could thereby amplify KIAA0391 activity through PKA-dependent mechanisms. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, may indirectly enhance KIAA0391 activity through altered downstream AKT signaling, impacting pathways KIAA0391 is involved with. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, may indirectly increase KIAA0391 function by affecting the MAPK pathway, which could intersect with KIAA0391's regulatory roles. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
GSK-3 inhibitor, could indirectly promote KIAA0391 activity by influencing the Wnt signaling pathway, potentially impacting KIAA0391's function. | ||||||